Philip Scheltens, MD, PhD, from VU University Medical Center, Amsterdam, the Netherlands, provides an overview of his session on imaging of Alzheimer’s disease at the 2nd Congress of the European Academy of Neurology (EAN), held in Copenhagen, Denmark, from May 28–31 2016, including the current use of imaging an increasing role of imaging for disease prediction and progression.
